Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$3.16B |
| 2 |
Merck
MRK
|
+$2.72B |
| 3 |
SLB Ltd
SLB
|
+$1.62B |
| 4 |
Target
TGT
|
+$1.6B |
| 5 |
General Mills
GIS
|
+$930M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.81B |
| 2 |
Blackrock
BLK
|
+$2.57B |
| 3 |
US Bancorp
USB
|
+$1.84B |
| 4 |
M&T Bank
MTB
|
+$808M |
| 5 |
Huntington Bancshares
HBAN
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Financials | 11.9% |
| 3 | Healthcare | 10.6% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Velocity Financial
VEL
$707M
| $1.41M | ﹤0.01% |
75,135
-4,746
| -6% | -$89.3K |
|
2727
Capital City Bank Group
CCBG
$897M
| $1.4M | ﹤0.01% |
39,000
-9
| -0% | -$326 |
|
2728
Annexon
ANNX
$903M
| $1.4M | ﹤0.01% |
725,752
-18,043
| -2% | -$60K |
|
2729
AlTi Global
ALTI
$481M
| $1.4M | ﹤0.01% |
459,698
-7,717
| -2% | -$27.6K |
|
|
ITOS
2730
DELISTED
iTeos Therapeutics
ITOS
| $1.39M | ﹤0.01% |
233,561
+34,365
| +17% | +$252K |
|
2731
LSI Industries
LYTS
$910M
| $1.39M | ﹤0.01% |
81,830
-65
| -0.1% | -$1.25K |
|
2732
SmartFinancial
SMBK
$897M
| $1.38M | ﹤0.01% |
44,446
-2
| -0% | -$66 |
|
2733
STMicroelectronics
STM
$48B
| $1.38M | ﹤0.01% |
62,873
+18,030
| +40% | +$443K |
|
2734
Mid Penn Bancorp
MPB
$959M
| $1.37M | ﹤0.01% |
52,991
+5,636
| +12% | +$159K |
|
2735
Farmers National Banc Corp
FMNB
$937M
| $1.35M | ﹤0.01% |
103,154
-6
| -0% | -$82 |
|
|
SLRN
2736
DELISTED
ACELYRIN
SLRN
| $1.35M | ﹤0.01% |
544,575
-69,899
| -11% | -$166K |
|
2737
KRONOS Worldwide
KRO
$966M
| $1.34M | ﹤0.01% |
179,158
-4,410
| -2% | -$38.9K |
|
|
CUK
2738
DELISTED
Carnival PLC
CUK
| $1.34M | ﹤0.01% |
76,317
+19,298
| +34% | +$416K |
|
2739
Tucows
TCX
$156M
| $1.34M | ﹤0.01% |
79,139
-1,282
| -2% | -$22.3K |
|
|
TSE
2740
DELISTED
Trinseo
TSE
| $1.33M | ﹤0.01% |
362,646
-164,278
| -31% | -$747K |
|
|
OLPX
2741
DELISTED
Olaplex Holdings
OLPX
| $1.33M | ﹤0.01% |
1,050,616
-25,072
| -2% | -$37.1K |
|
|
FSP
2742
Franklin Street Properties
FSP
$46.6M
| $1.33M | ﹤0.01% |
748,965
+111,304
| +17% | +$205K |
|
2743
Ginkgo Bioworks
DNA
$550M
| $1.33M | ﹤0.01% |
233,150
-567
| -0.2% | -$5.78K |
|
2744
Definitive Healthcare
DH
$71.7M
| $1.33M | ﹤0.01% |
458,936
+38,443
| +9% | +$156K |
|
2745
Amylyx Pharmaceuticals
AMLX
$2.66B
| $1.32M | ﹤0.01% |
372,853
+73,904
| +25% | +$263K |
|
2746
James River Group Holdings
JRVR
$221M
| $1.31M | ﹤0.01% |
312,692
-67,088
| -18% | -$305K |
|
2747
Olema Pharmaceuticals
OLMA
$1.02B
| $1.31M | ﹤0.01% |
349,023
+16,073
| +5% | +$80.8K |
|
2748
Climb Global Solutions
CLMB
$500M
| $1.31M | ﹤0.01% |
47,372
+24
| +0.1% | +$741 |
|
2749
Tactile Systems Technology
TCMD
$648M
| $1.31M | ﹤0.01% |
99,175
-28,000
| -22% | -$441K |
|
2750
RE/MAX Holdings
RMAX
$230M
| $1.31M | ﹤0.01% |
156,099
+4,320
| +3% | +$41.2K |
|
Similar funds
Charles Schwab's Q1 2025 Portfolio in Review
As of Q1 2025, Charles Schwab held 3,548 positions worth $533B, down 1.7% from $542B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.6%. Charles Schwab opened 55 new positions and exited 74, leaving the 3,548-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2025 buy was iShares Currency Hedged MSCI Eurozone ETF: 7,259,426 shares worth $283M.
- Charles Schwab added most to ConocoPhillips in Q1 2025, an estimated $3.16B increase.
- Charles Schwab's biggest Q1 2025 reduction was Pfizer, cutting an estimated $2.81B.
- Charles Schwab fully exited Brookfield in Q1 2025, selling an estimated $218M.
- Charles Schwab's ten largest holdings make up 20% of its $533B portfolio in Q1 2025.
- Charles Schwab opened 55 new positions and closed 74 in Q1 2025.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $533B.
Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.